about
Aspirin use and cancers of the upper aerodigestive tractEffects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysisRegular aspirin use and lung cancer risk.Promoter methylation regulates cyclooxygenase expression in breast cancerEarly events during neoplastic progression in Barrett's esophagusUse of acetaminophen in relation to the occurrence of cancer: a review of epidemiologic studiesCancer chemoprevention: Much has been done, but there is still much to do. State of the art and possible new approachesAspirin use and lung cancer in menProstate cancer and use of nonsteroidal anti-inflammatory drugs: systematic review and meta-analysisEvidence for colorectal cancer cell specificity of aspirin effects on NF kappa B signalling and apoptosisRisk of breast cancer among users of aspirin and other anti-inflammatory drugsType-II diabetes and pancreatic cancer: a meta-analysis of 36 studiesAspirin induces apoptosis through release of cytochrome c from mitochondriaAspirin and risk for gastric cancer: a population-based case-control study in SwedenLong-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancerCOX-2 and cancer: a new approach to an old problemAspirin and lung cancer in womenA population-based cohort study of the risk of colorectal and other cancers among users of low-dose aspirinOesophageal squamous cell neoplasia in head and neck cancer patients: upregulation of COX-2 during carcinogenesisRisk of cancer in a large cohort of nonaspirin NSAID users: a population-based studyUse of nonsteroidal anti-inflammatory drugs and risk of oral cancer: a cohort studyAspirin-induced nuclear translocation of NFkappaB and apoptosis in colorectal cancer is independent of p53 status and DNA mismatch repair proficiencyInduction of lung lesions in Wistar rats by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and its inhibition by aspirin and phenethyl isothiocyanateAnalgesic and anti-inflammatory drug use and risk of bladder cancer: a population based case control studySecondary chemoprevention of Barrett's esophagus with celecoxib: results of a randomized trialAspirin and lung cancer risk in a cohort study of women: dosage, duration and latencyRole of cyclooxygenase-2 in the carcinogenesis of gastrointestinal tract cancers: a review and report of personal experienceInduction of cyclo-oxygenase-2 mRNA by prostaglandin E2 in human prostatic carcinoma cellsMolecular biology of Barrett's adenocarcinoma.Cyclooxygenase-2 and the inflammogenesis of breast cancer.Prognostic significance of cyclooxygenase-2 (COX-2) expression in patients with surgically resectable adenocarcinoma of the oesophagusBortezomib in combination with celecoxib in patients with advanced solid tumors: a phase I trial.Non-Steroidal Anti-Inflammatory Drugs in the Carcinogenesis of the Gastrointestinal Tract.Tumor formation in a mouse model of colitis-associated colon cancer does not require COX-1 or COX-2 expression.Expression of COX-2, PCNA, Ki-67 and p53 in gastrointestinal stromal tumors and its relationship with histopathological parametersCyclooxygenase-2 and epithelial growth factor receptor up-regulation during progression of Barrett's esophagus to adenocarcinomaPrescriptions for selective cyclooxygenase-2 inhibitors, non-selective non-steroidal anti-inflammatory drugs, and risk of breast cancer in a population-based case-control studyAt the bedside: Helicobacter pylori, dysregulated host responses, DNA damage, and gastric cancer.COX-2 gene expression in colon cancer tissue related to regulating factors and promoter methylation statusDecreased risk of squamous cell carcinoma of the head and neck in users of nonsteroidal anti-inflammatory drugs
P2860
Q24657400-3DB4DD67-23CB-4295-B917-F6A4E98DC676Q24796323-0C44033A-80FD-4964-82FC-C50B1BBEB979Q24803838-88C43A66-7BBD-4380-9F77-FB2BF2350E20Q24805995-89C325AD-0B49-46CD-9899-7A3CA04DD033Q26825349-3AA369BF-F442-4C90-A93A-2D91C6B9E9CCQ28075857-1F288532-2D06-4F71-B5F4-08EA86726F4CQ28080472-3191A062-57C7-49CE-BB07-191E5CECA91FQ28165856-63468142-6D46-4045-B04C-C657375ABC7AQ28166676-26036ADC-3AA7-41FC-9A0F-63D1EAAA1306Q28168893-9D59A219-0E6D-4AB0-98E4-CF595080B53FQ28169157-0C1247BB-4D46-4E35-ACC2-4E809D70C75FQ28175267-B25E4FC5-280D-4B09-BD53-2AB7518F4931Q28176509-4817B62C-7AAC-44F9-964A-ADB9D05BB5DBQ28181380-FB853FB6-4D27-470C-BD81-154796B1683BQ28188848-041A4F29-D3A5-4782-8DBF-136D0B3A20E1Q28191533-21D4B2A3-74B0-4094-8DC0-16B1290019B2Q28193281-7B19F920-4D41-48DB-8F57-A41F4E76EE23Q28195221-A517D957-214E-45CE-A74C-3FFEFE2FDBFCQ28195678-04840211-BF6C-4596-A98C-E77972751628Q28196301-13B424CD-415D-424E-A889-398DD7EDAE01Q28199772-C40ECD7D-6932-446F-B212-A87ECDA8CF54Q28210586-E6827E08-B67F-4166-83D4-3CBAEE6CBDFBQ28211715-2047F671-A742-4C3A-A9D3-FE40F3EAB814Q28219349-A751E277-4182-48D6-9698-08F5622A9E48Q28222007-356B1472-70B2-4F03-AB0C-9C52DECCB5DAQ28222207-3225CF1C-6407-4A2B-960F-776FB7AB2DFEQ28303196-81605640-053B-4C18-B55C-0464F384131CQ28379538-B4423169-1C3A-4022-A6B5-0C44AFAA9269Q30327935-7040148F-A93C-433E-B26C-1066AFA0244CQ30367680-5D0991DD-27B7-46BF-8580-AF674B27A7F7Q33244119-1B13DCC6-EAB5-4015-924E-EFB44CD83D67Q33308317-B0305B9F-D511-4283-B387-85011E3FD93CQ33664095-62859A43-E894-4411-B3F3-E7A0D64D6BA5Q33759698-0F6C8DD3-D2D3-44A3-9EB0-91A10848E80CQ33787627-16FB59FE-F255-4D70-A883-2DA656B0CD17Q33788585-E68A4E2C-205E-439E-8523-33720F05BD86Q33889458-7BE22BC4-C996-4A20-922F-66E9953A2D60Q33911623-D27DC5BA-419D-4F02-8445-11FFFD65DACBQ33930978-890E00AD-C6C0-4569-A05A-D76FD1B5DFC9Q33984604-7FA438EA-DD6D-40FA-B543-634CBCC928BB
P2860
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Aspirin use and risk of fatal cancer.
@en
type
label
Aspirin use and risk of fatal cancer.
@en
prefLabel
Aspirin use and risk of fatal cancer.
@en
P2093
P1433
P1476
Aspirin use and risk of fatal cancer.
@en
P2093
Flanders WD
Heath CW Jr
Namboodiri MM
P304
P407
P577
1993-03-01T00:00:00Z